SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 4 filers reported holding SEATTLE GENETICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $702,216 | +32.7% | 3,310 | +20.4% | 0.04% | +37.9% |
| Q2 2023 | $529,265 | -4.9% | 2,750 | 0.0% | 0.03% | -12.1% |
| Q1 2023 | $556,792 | +57.6% | 2,750 | 0.0% | 0.03% | +50.0% |
| Q4 2022 | $353,402 | -6.0% | 2,750 | 0.0% | 0.02% | -15.4% |
| Q3 2022 | $376,000 | -22.8% | 2,750 | 0.0% | 0.03% | -18.8% |
| Q2 2022 | $487,000 | +23.0% | 2,750 | 0.0% | 0.03% | +45.5% |
| Q1 2022 | $396,000 | -6.8% | 2,750 | 0.0% | 0.02% | +4.8% |
| Q4 2021 | $425,000 | -9.0% | 2,750 | 0.0% | 0.02% | -19.2% |
| Q3 2021 | $467,000 | +64.4% | 2,750 | +52.8% | 0.03% | +62.5% |
| Q2 2021 | $284,000 | +13.6% | 1,800 | 0.0% | 0.02% | +6.7% |
| Q1 2021 | $250,000 | -20.6% | 1,800 | 0.0% | 0.02% | -25.0% |
| Q4 2020 | $315,000 | +21.6% | 1,800 | +35.8% | 0.02% | +5.3% |
| Q3 2020 | $259,000 | +13.1% | 1,325 | -1.5% | 0.02% | +5.6% |
| Q2 2020 | $229,000 | – | 1,345 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 57,170 | $10,013,000 | 5.39% |
| Boxer Capital, LLC | 400,000 | $70,056,000 | 2.25% |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | 110,153 | $19,292,000 | 1.10% |
| DCF Advisers, LLC | 13,300 | $2,329,000 | 0.96% |
| XTX MARKETS LLC | 2,418 | $423,000 | 0.87% |
| FAIRFIELD, BUSH & CO. | 15,035 | $2,633,000 | 0.77% |
| Parcion Private Wealth LLC | 4,520 | $792,000 | 0.10% |
| Gulf International Bank (UK) Ltd | 26,091 | $4,569,000 | 0.06% |
| Princeton Portfolio Strategies Group LLC | 1,500 | $263,000 | 0.05% |
| Redpoint Investment Management Pty Ltd | 2,392 | $419,000 | 0.04% |